11 trials changed in the last 30 days: 0 stopped, 6 with notable changes, 5 with minor changes only.
Results posted: Oct 9, 2026
Also in this update: Primary endpoint(s) modified; Trial completed
University of California, DavisNot specified NCT05886218 Registry history of NCT05886218 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 2026 to Sep 2027
University of California, DavisEarly Phase 1 NCT05876858 Registry history of NCT05876858 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jun 30, 2026 to Jul 14, 2027
University of California, DavisNot specified NCT02754037 Registry history of NCT02754037 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jun 27, 2026 to Jun 27, 2027
University of California, DavisNot applicable NCT04141878 Registry history of NCT04141878 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 30, 2026 to May 31, 2033
University of California, DavisNot applicable NCT04881656 Registry history of NCT04881656 on ClinicalTrials.gov (opens the registry)
Primary and study completion dates pushed to Sep 2, 2027
University of California, DavisNot applicable NCT03221244 Registry history of NCT03221244 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Primary and study completion pushed from Sep 2026 to Jan 2027; Final enrollment: 28 participants (planned 25)
University of California, DavisNot applicable NCT06032104 Registry history of NCT06032104 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
University of California, DavisPhase 2 NCT05600686 Registry history of NCT05600686 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Aug 31, 2026 to Dec 31, 2026
University of California, DavisNot applicable NCT05027789 Registry history of NCT05027789 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 1, 2026 to Dec 31, 2026
University of California, DavisNot applicable NCT06662214 Registry history of NCT06662214 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 20 → 25 participants
Also in this update: Primary completion moved earlier from Jul 2027 to Mar 2027; Study completion moved earlier from Dec 2027 to Sep 2027
University of California, DavisPhase 1 NCT07145112 Registry history of NCT07145112 on ClinicalTrials.gov (opens the registry)
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-22 | NCT07888166 Autologous Skin Cell Suspension (RECELL®) for Accelerated Healing of Split-Thickness Skin… | Not Yet Recruiting |
| Early Phase 1 | 6 | |
| Phase 1 | 16 | |
| Phase 1/2 | 3 | |
| Phase 2 | 17 | |
| Phase 2/3 | 3 | |
| Phase 3 | 2 | |
| Phase 4 | 9 |
Obesity (12) · Diabetes (11) · Heart Disease (10) · Lung Cancer (8) · Non-Hodgkin Lymphoma (6) · Breast Cancer (5) · Depression (5) · Epilepsy (5) · Prostate Cancer (5) · Bladder Cancer (4)